and immune disorders. We are currently seeking a Global Oncology Business Strategy and Analytics Intern from for Summer 2026..., under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo...
and immune disorders. We are currently seeking a Global Business Strategy & Analytics Intern for Summer 2026. This full-time..., under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo...
and immune disorders. We are currently seeking a Business Operations - Analytics Intern for Summer 2026. This part-time..., under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo...
, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo... is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases...